• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proteinase inhibitors from Streptomyces with antiviral activity

Mingus

Well-known member
[SIZE=+1] Original Paper[/SIZE]
<table width="100%"><tbody><tr><td>Proteinase inhibitors from Streptomyces with antiviral activity
</td></tr><tr><td>Julia Serkedjieva, Dr.<sup>[SIZE=-1] 1[/SIZE][SIZE=-1] *[/SIZE]</sup>, Lidiya Angelova<sup>[SIZE=-1] 1 2[/SIZE]</sup>, Mimi Remichkova<sup>[SIZE=-1] 1[/SIZE]</sup>, Iskra Ivanova<sup>[SIZE=-1] 2[/SIZE]</sup></td></tr><tr><td><sup>[SIZE=-1]1[/SIZE]</sup>Institute of Microbiology, Bulgarian Academy of Sciences
<sup>[SIZE=-1]2[/SIZE]</sup>Department of Microbiology, Sofia University, Sofia, Bulgaria
</td></tr><tr><td>email: Julia Serkedjieva (jserkedjieva@microbio.bas.bg)</td></tr></tbody></table><sup>[SIZE=-1]*[/SIZE]</sup>Correspondence to Julia Serkedjieva, Tel.: (359 2) 979 31 85, Fax: (359 2) 70 01 09
<script language="JavaScript">setDOI("ADOI=10.1002/jobm.200510127")</script><table border="0" width="100%"><tbody><tr><td class="mainSectionHeader">Abstract</td></tr></tbody></table><table border="0" width="100%"><tbody><tr><td>An extensive screening study for the production of proteolytic inhibitors has been carried out on 75 Streptomyces strains. It was found that 18 of the strains and/or their variants (24%) produced proteinaceous substances, which belonged to the group of typical serine protease inhibitors. 23 samples were tested for inhibitory activity on the replication of influenza virus A/Germany/34, strain Rostock (H7N1) (A/Rostock) in chicken embryonic fibroblast (CEF) cells. Eleven of the tested samples (52.2%) significantly inhibited viral growth. Further the specific inhibitory effect on the replication of influenza virus A/Aichi/2/68 (H3N2) (A/Aichi) in Madin-Darby canine kidney (MDCK) cells and on the growth of herpes simplex virus type 1, strain DA (HSV-1) in Madin-Darby bovine kidney (MDBK) cells was tested. Nine samples significantly inhibited A/Aichi and four - HSV-1. The most effective inhibitors, produced by Streptomyces sp. 225b (SS 225b) and Streptomyces chromofuscus 34-1 (SS 34-1) protected mice from mortality in the experimental influenza A/Aichi virus infection. (? 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)</td></tr></tbody></table><hr align="left" size="1" width="25%">Received: 6 December 2005; Accepted: 28 January 2006<table border="0" width="100%"><tbody><tr><td class="mainSectionHeader">Digital Object Identifier (DOI)</td></tr></tbody></table>
10.1002/jobm.200510127 About DOI
 
Back
Top